Overview

Pharmacokinetic Drug Interaction Study in Healthy Male Subjects

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
A Randomized, Open Label, Drug-Drug interaction study to investigate effect of ketoconazole or rifampicin on the Pharmacokinetic characteristics and safety of LC15-0444 in Healthy Male Volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
LG Life Sciences
Treatments:
Ketoconazole
Rifampin